Collab Network
Our Collab Network members are not only experts within their own domain but educators with the research community. Learn more about the discoveries and findings our collaborators are achieving with IDT.
Member spotlight:
Manja Meggendorfer, PhD
The future of personalized genomics
Manja Meggendorfer is the Head of Molecular Genetics at Munich Leukemia Laboratory (MLL), where she oversees various R&D activities such as the 5,000 genome project, which is aimed at better understanding the genetic factors behind leukemia. She received her Master of Science in Biology from the Ludwig-Maximilians-University in Munich and her PhD. in collaboration with the Helmholtz Center Munich working on gene regulation within the architecture of the cell nucleus. After her post-doctorate, she moved to the field of hematology as a scientist in the department of molecular genetics at MLL. In combination with her MBA in Health Care Management, Manja hopes to improve the diagnostic and prognostic work associated with routine diagnostic approaches for leukemia or lymphoma patients.
Geneseeq Technology
Leveraging cutting-edge genomic profiling technology to advance cancer care
Geneseeq is a research-driven company that provides next generation sequencing (NGS) technology to accelerate precision cancer care. With headquarters in both Canada and China, Geneseeq focuses on clinical genetic testing and translational research covering all cancers and sample types. The company provides a full suite of next generation sequencing services to facilitate the research and creative endeavors of those in academia and industry. The company offers both pan-cancer panels analyzing more than 400 genes and cancer-type specific gene panels to help match patients to optimal treatments, including targeted therapy and immunotherapy.
Click on the featured content below to learn how Geneseeq, in collaboration with IDT, is accelerating precision cancer research!